Chemomab Therapeutics (CMMB) Short Interest Ratio & Short Volume → Thousands of investors use this no cost solution | Do you? (From Insider Financial) (Ad) Free CMMB Stock Alerts $0.66 -0.01 (-1.49%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Chemomab Therapeutics Short Interest DataCurrent Short Volume155,800 sharesPrevious Short Volume221,900 sharesChange Vs. Previous Month-29.79%Dollar Volume Sold Short$113,734.00Short Interest Ratio / Days to Cover0.7Last Record DateApril 15, 2024Outstanding Shares11,050,000 sharesFloat Size11,870,000 sharesShort Percent of Float1.31%Today's Trading Volume11,539 sharesAverage Trading Volume190,684 sharesToday's Volume Vs. Average6% Short Selling Chemomab Therapeutics ? Sign up to receive the latest short interest report for Chemomab Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCMMB Short Interest Over TimeCMMB Days to Cover Over TimeCMMB Percentage of Float Shorted Over Time Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. Chemomab Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024155,800 shares $113,734.00 -29.8%1.3%0.7 $0.73 3/31/2024221,900 shares $172,860.10 +14.3%1.9%1 $0.78 3/15/2024194,200 shares $155,224.06 -20.5%1.8%0.8 $0.80 2/29/2024244,300 shares $167,345.50 +549.7%2.5%0.9 $0.69 2/15/202437,600 shares $22,936.00 +15.7%0.4%0.1 $0.61 1/31/202432,500 shares $18,752.50 +5.5%0.3%0 $0.58 Get the Latest News and Ratings for CMMB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/202430,800 shares $17,217.20 -23.8%0.3%0 $0.56 12/31/202340,400 shares $20,604.00 +125.7%0.3%0 $0.51 12/15/202317,900 shares $9,039.50 -84.8%0.1%0 $0.51 11/30/2023117,900 shares $63,548.10 +287.8%1.2%0.1 $0.54 11/15/202330,400 shares $24,836.80 -5.6%0.3%0 $0.82 10/31/202332,200 shares $23,583.28 -28.1%0.3%1.7 $0.73 10/15/202344,800 shares $39,827.20 -2.6%0.5%2.4 $0.89 9/30/202346,000 shares $41,170.00 +23.0%0.5%2 $0.90 9/15/202337,400 shares $40,766.00 -9.2%0.4%0.7 $1.09 8/31/202341,200 shares $45,732.00 -8.9%0.4%0.2 $1.11 8/15/202345,200 shares $50,624.00 -19.6%0.5%0.3 $1.12 7/31/202356,200 shares $71,936.00 -43.4%0.5%0.3 $1.28 7/15/202399,200 shares $139,872.00 +6.6%0.9%0.6 $1.41 6/30/202393,100 shares $121,961.00 -69.1%1.1%0.5 $1.31 6/15/2023301,700 shares $512,890.00 -7.6%3.4%1.8 $1.70 5/31/2023326,500 shares $512,605.00 -22.8%3.7%11.9 $1.57 5/15/2023422,900 shares $689,327.00 -7.3%4.8%5.7 $1.63 4/30/2023456,300 shares $679,887.00 -11.8%4.9%1 $1.49 4/15/2023517,400 shares $838,188.00 +1.5%5.6%1.1 $1.62 3/31/2023510,000 shares $810,900.00 -15.7%5.5%1.1 $1.59 3/15/2023605,200 shares $913,852.00 -8.2%7.1%0.7 $1.51 2/28/2023658,900 shares $1.02 million +457.9%7.7%0.8 $1.55 2/15/2023118,100 shares $237,381.00 +3.9%1.4%0.1 $2.01 1/31/2023113,700 shares $261,510.00 -24.8%1.4%0.3 $2.30 1/15/2023151,200 shares $341,712.00 +269.7%1.8%0.3 $2.26 12/30/202240,900 shares $130,880.00 -19.7%0.5%0.1 $3.20 12/15/202250,900 shares $109,435.00 +155.8%0.6%1 $2.15 11/30/202219,900 shares $41,790.00 -69.9%0.3%0.5 $2.10 11/15/202266,100 shares $134,844.00 +66,000.0%0.8%1.6 $2.04 10/31/2022100 shares $204.00 No ChangeN/A0 $2.04 10/15/2022100 shares $200.00 -93.3%N/A0 $2.00 9/30/20221,500 shares $3,735.00 -83.0%0.0%0 $2.49 9/15/20228,800 shares $28,776.00 -36.7%0.1%0.2 $3.27 8/31/202213,900 shares $45,592.00 -42.3%0.2%0.3 $3.28Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide CMMB Short Interest - Frequently Asked Questions What is Chemomab Therapeutics' current short interest? Short interest is the volume of Chemomab Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 155,800 shares of CMMB short. 1.31% of Chemomab Therapeutics' shares are currently sold short. Learn More on Chemomab Therapeutics' current short interest. What is a good short interest ratio for Chemomab Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CMMB shares currently have a short interest ratio of 1.0. Learn More on Chemomab Therapeutics's short interest ratio. What is a good short interest percentage for Chemomab Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.31% of Chemomab Therapeutics' floating shares are currently sold short. Is Chemomab Therapeutics' short interest increasing or decreasing? Chemomab Therapeutics saw a drop in short interest in April. As of April 15th, there was short interest totaling 155,800 shares, a drop of 29.8% from the previous total of 221,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Chemomab Therapeutics' float size? Chemomab Therapeutics currently has issued a total of 11,050,000 shares. Some of Chemomab Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Chemomab Therapeutics currently has a public float of 11,870,000 shares. How does Chemomab Therapeutics' short interest compare to its competitors? 1.31% of Chemomab Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Chemomab Therapeutics: Pasithea Therapeutics Corp. (1.34%), Kineta, Inc. (1.23%), Bionomics Limited (2.03%), TFF Pharmaceuticals, Inc. (2.77%), Biofrontera Inc. (1.20%), eFFECTOR Therapeutics, Inc. (7.16%), ASLAN Pharmaceuticals Limited (1.47%), Trevena, Inc. (0.33%), Clever Leaves Holdings Inc. (0.61%), Lixte Biotechnology Holdings, Inc. (4.59%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Chemomab Therapeutics stock? Short selling CMMB is an investing strategy that aims to generate trading profit from Chemomab Therapeutics as its price is falling. CMMB shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Chemomab Therapeutics? A short squeeze for Chemomab Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CMMB, which in turn drives the price of the stock up even further. How often is Chemomab Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CMMB, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Pasithea Therapeutics Short Interest Data Kineta Short Interest Data Bionomics Short Interest Data TFF Pharmaceuticals Short Interest Data Biofrontera Short Interest Data eFFECTOR Therapeutics Short Interest Data ASLAN Pharmaceuticals Short Interest Data Trevena Short Interest Data Clever Leaves Short Interest Data Lixte Biotechnology Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CMMB) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings